ANNE HALE: Open Payments
NPI 1306613831 · SCOTTSBLUFF, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 49 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $631 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $187 |
| Amgen Inc. | 6 | $119 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Eisai Inc. | 3 | $67 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $26 |
Products named: CAPLYTA, QULIPTA, REXULTI, KRYSTEXXA, Leqembi, FANAPT, OTEZLA, AIRSUPRA.
Industry payments across NE — which companies pay providers there.
